SBC Medical Group Holdings Incorporated (SBC) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $314.71M | Exchange | NASDAQ |
| Sector | Industrials | Industry | Consulting Services |
| Country | US | CEO | Yoshiyuki Aikawa |
| IPO Date | 2022-09-26 | CAGR | -0.11% |
| Employees | 863 | Website | sbc-holdings.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 2.52% | Total Yield | 2.52% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $277.80M | P/E | 7.85 | Forward P/E | 6.31 | PEG | -0.16 |
| P/S | 1.17 | P/B | 0.77 | P/CF | 4.29 | P/FCF | 4.54 |
| Sales | $169.34M | Sales 1Y | -14.45% | Sales 3Y | — | Sales 5Y | — |
| EPS | $0.39 | EPS 1Y | -21.77% | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | 8.83% | EPS QoQ | -21.43% | Sales QoQ Avg | -2.08% | EPS QoQ Avg | 77.69% |
| Gross Margin | 70.2% | Operating Margin | 36.02% | Profit Margin | 24.09% | ROCE | 18.74% |
| ROA | 11% | ROE | 16% | Altman Z Score | 4.06 | Piotroski Score | 6 |
| Current Ratio | 3.82 | Quick Ratio | 3.78 | Cash Ratio | 2.67 | Op. CF Ratio | 0.15 |
| Debt/Equity | 0.08 | Debt/Assets | 0.05 | Lt Debt/Equity | 0.02 | Lt Debt/Cap. | 0.02 |
| Intrst Cov. | 226.63 | Inventory Turnover | 21.71 | Asset Turnover | 0.44 | Receivables Turnover | 12.93 |
| Enterprise Value | $277.80M | P/E Ratio | 7.85 |
| Forward P/E | 6.31 | PEG Ratio | -0.16 |
| P/S Ratio | 1.17 | P/B Ratio | 0.77 |
| P/CF Ratio | 4.29 | P/FCF Ratio | 4.54 |
| EPS | $0.39 | EPS Growth 1Y | -21.77% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -14.45% | Gross Margin | 0.7% |
| Operating Margin | 0.36% | Profit Margin | 0.24% |
| ROE | 0.16% | ROA | 0.11% |
| ROCE | 0.19% | Current Ratio | 3.82 |
| Quick Ratio | 3.78 | Cash Ratio | 2.67 |
| Debt/Equity | 0.08 | Interest Coverage | 226.63 |
| Altman Z Score | 4.06 | Piotroski Score | 6 |
View SBC Medical Group Holdings Incorporated financial charts →
SBC Medical Group Holdings Incorporated (SBC) valuation & financials
SBC Medical Group Holdings Incorporated (SBC) has a market capitalization of $314.71M and trades at a price-to-earnings ratio of 7.8. It operates in the Industrials sector (Consulting Services).
SBC Medical Group Holdings Incorporated's revenue grew -14.4% over the last year.
SBC Medical Group Holdings Incorporated's next earnings report is scheduled for August 12, 2026; analysts estimate EPS of $0.12.
SBC Medical Group Holdings Incorporated (SBC) — frequently asked questions
When does SBC Medical Group Holdings Incorporated (SBC) report earnings next?
SBC Medical Group Holdings Incorporated is expected to report earnings on August 12, 2026. Analysts estimate EPS of $0.12.
What is SBC Medical Group Holdings Incorporated's market cap?
SBC Medical Group Holdings Incorporated (SBC) has a market capitalization of $314.71M.
What is SBC's P/E ratio?
SBC Medical Group Holdings Incorporated trades at a price-to-earnings ratio of 7.8, with trailing twelve-month EPS of $0.39.
How fast is SBC Medical Group Holdings Incorporated growing?
SBC Medical Group Holdings Incorporated's revenue grew -14.4% over the last year.
Compare with other Industrials companies: Caterpillar (CAT) · General Electric (GE) · Raytheon Technologies (RTX) · CATL (300750.SZ) · Siemens (SIE.DE) · Airbus (AIR.PA)
SBC Medical Group Holdings Incorporated revenue & earnings charts →